Elite Pharmaceuticals (ELTP) Price to Sales (2011 - 2026)
Elite Pharmaceuticals' Price to Sales was 2.83 in fiscal Q1 2027 (quarter ended Jun 30, 2026), down 61.9% from 7.41 a year earlier but up 8.5% from the prior quarter.
Powered by 
Analysis
Elite Pharmaceuticals (ELTP) Price to Sales (2011 - 2026) Analysis & Trends
For FY2026 (ended Mar 31, 2026), Price to Sales at Elite Pharmaceuticals came in at 2.60, down 53.4% from FY2025.
- In earlier fiscal years, Price to Sales was 5.59 in FY2025 (+97.7%), 2.83 in FY2024 (+217.8%), 0.89 in FY2023 (-5.3%) and 0.94 in FY2022 (-60.6%).
- Quarterly Price to Sales has moved between 0.89 (fiscal Q4 2023) and 8.24 (fiscal Q3 2025) over five years.
- Compared with a year earlier, Price to Sales has declined for four straight quarters, with growth averaging 48.9% over the last eight quarters.
- The best year-over-year quarter for Price to Sales over five years was fiscal Q3 2024 (growth of 228.5%); the worst was fiscal Q1 2027 (a decline of 61.9%).
- Per Business Quant data, ELTP's Price to Sales in the three fiscal quarters before Q1 2027 was 2.60 (Q4 2026), 3.77 (Q3 2026) and 5.60 (Q2 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,199.50 Bn | 1,168.08 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 635.17 Bn | 555.03 Bn | 17.30 Bn |
| 3 | AbbVie | 504.69 Bn | 477.85 Bn | 12.70 Bn |
| 4 | Merck | 358.43 Bn | 312.86 Bn | 12.21 Bn |
| 5 | Novartis Ag | 288.36 Bn | 252.75 Bn | 11.24 Bn |
| 6 | Astrazeneca | 265.78 Bn | 239.54 Bn | 12.86 Bn |
| 7 | Amgen | 237.46 Bn | 192.86 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 193.65 Bn | 167.76 Bn | 6.22 Bn |
| 9 | Pfizer | 171.05 Bn | 118.00 Bn | 10.94 Bn |
| 10 | Elite Pharmaceuticals | 269.28 Mn | 150.96 Mn | 13.51 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.83 |
| Mar 31, 2026 | 2.60 |
| Dec 31, 2025 | 3.77 |
| Sep 30, 2025 | 5.60 |
| Jun 30, 2025 | 7.41 |
| Mar 31, 2025 | 5.59 |
| Dec 31, 2024 | 8.24 |
| Sep 30, 2024 | 5.85 |
| Jun 30, 2024 | 3.22 |
| Mar 31, 2024 | 2.83 |
| Dec 31, 2023 | 3.01 |
| Sep 30, 2023 | 2.22 |
| Jun 30, 2023 | 1.14 |
| Mar 31, 2023 | 0.89 |
| Dec 31, 2022 | 0.92 |
| Sep 30, 2022 | 1.23 |
| Jun 30, 2022 | 1.54 |
| Mar 31, 2022 | 0.94 |
| Dec 31, 2021 | 1.05 |
| Sep 30, 2021 | 1.55 |
API Access
Elite Pharmaceuticals Price to Sales API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=price-to-sales&ticker=ELTP&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "price-to-sales", "ticker": "ELTP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=price-to-sales&ticker=ELTP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();